Company intelligence / Profile preview

MLV Pharmaceuticals

Athens, Attica, Greece

Ownership: Private
Development stage: Other

Overview

MLV Pharmaceuticals is a biotechnology company focused on the design and development of advanced liposomal drug delivery systems. The company specializes in reformulating established therapeutic agents into lipid-based nanocarriers to improve their pharmacokinetic properties, enhance targeting, and reduce systemic toxicity. Their research and development efforts primarily target oncology and inflammatory conditions, leveraging proprietary nanotechnology to create more effective treatments. MLV Pharmaceuticals maintains strong ties with academic research institutions to translate innovative nanomedicine concepts into clinical-stage products.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: LiposomeNanoparticleSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on MLV Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MLV Pharmaceuticals.

Explore the full profile